Prevalence of antibiotic use: A comparison across various European health care data sources

Pharmacoepidemiology and Drug Safety

Volumn 25, Issue , 2016, Pages 11-20

  Brauer, Ruth ^a   Ruigómez, Ana ^b   Downey, Gerry ^c   Bate, Andrew ^d   Garcia Rodriguez, Luis Alberto ^b   Huerta, Consuelo ^e   Gil, Miguel ^e   de Abajo, Francisco ^f,g   Requena, Gema ^g   Alvarez, Yolanda ^h   Slattery, Jim ^h   de Groot, Mark ⁱ   Souverein, Patrick ⁱ   Hesse, Ulrik ^j   Rottenkolber, Marietta ^k   Schmiedl, Sven ^l,m   de Vries, Frank ^i,n,o   Tepie, Maurille Feudjo ^c   Schlienger, Raymond ^p   Smeeth, Liam ^a   Douglas, Ian ^a   Reynolds, Robert ^q   Klungel, Olaf ⁱ   more..

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b Fundación Centro Español de Investigación Farmacoepidemiológica ^*  (Spain)

^c Amgen NV   (United Kingdom)

^d PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United Kingdom)

^e Agencia Espanola de Medicamentos y Productos Sanitarios   (Spain)

^f HOSPITAL UNIVERSITARIO PRÍNCIPE DE ASTURIAS   (Spain)

^g UNIVERSITY OF ALCALÁ   (Spain)

^h EUROPEAN MEDICINES AGENCY   (United Kingdom)

ⁱ UTRECHT UNIVERSITY   (Netherlands)

^j DANISH MEDICINES AGENCY   (Denmark)

^k UNIVERSITY OF MUNICH   (Germany)

^l UNIVERSITY OF WITTEN HERDECKE   (Germany)

^m HELIOS KLINIKUM WUPPERTAL   (Germany)

ⁿ SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

^o MAASTRICHT UNIVERSITY   (Netherlands)

^p NOVARTIS PHARMA AG   (Switzerland)

^q PFIZER INC   (United States)

more..

Author keywords

Antibiotic agents; Descriptive study; International comparisons; Pharmacoepidemiology; Primary care databases

Indexed keywords

ANTIBIOTIC AGENT; PENICILLIN DERIVATIVE; ANTIINFECTIVE AGENT;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ANTIBIOTIC THERAPY; ARTICLE; CHILD; DRUG USE; EUROPEAN; FEMALE; GROUPS BY AGE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; PRESCRIPTION; PREVALENCE; PRIMARY HEALTH CARE; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; SEASONAL VARIATION; SEX DIFFERENCE; SEX RATIO; VERY ELDERLY; CLINICAL PRACTICE; COMPARATIVE STUDY; DATA BASE; DRUG UTILIZATION; EPIDEMIOLOGY; EUROPE; HEALTH CARE DELIVERY; STATISTICS AND NUMERICAL DATA; TRENDS;

ANTI-BACTERIAL AGENTS; DATABASES AS TOPIC; DELIVERY OF HEALTH CARE; DRUG UTILIZATION; EUROPE; PRACTICE PATTERNS, PHYSICIANS';

EID: 84936797442     PISSN: 10538569     EISSN: 10991557     Source Type: Journal    
DOI: 10.1002/pds.3831     Document Type: Article

References (25)

1. Adriaenssens N, Coenen S, Versporten A, et al. European Surveillance of Antimicrobial Consumption (ESAC): outpatient antibiotic use in Europe (1997-2009). J Antimicrob Chemother. Dec 2011; 66Suppl 6: vi3-12.
2. Goossens H, Ferech M, Vander Stichele R, Elseviers M. Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. Lancet. Feb 12-18 2005; 365(9459): 579-587.
3. Molstad S, Lundborg CS, Karlsson AK, Cars O. Antibiotic prescription rates vary markedly between 13 European countries. Scand J Infect Dis 2002; 34(5): 366-371.
4. Bjerrum L MA, Reutskiy A, Llor C, Cots JM, Caballero L, Ovhed I, Strandberg E, Radzeviciene R, Gahrn-Hansen B. Respiratory tract infections in general practice: total results 2008/2009 from 6 countries and 618/511 GPs. 2010. http://www.happyaudit.org/files/pub/4398.pdf. Accessed December 17, 2012.
5. Clinical Practice Research Datalink . Observational data. http://www.cprd.com/ObservationalData/CodedData.asp#Primarycare. Accessed December 17, 2012.
6. The Health Improvement Network (THIN). http://www.thin-uk.com. Accessed December 17, 2012.
7. Salvador Rosa A, Moreno Perez JC, Sonego D, Garcia Rodriguez LA, de Abajo Iglesias FJ. The BIFAP project: database for pharmaco-epidemiological research in primary care. Aten Primaria. Dec 2002; 30(10): 655-661.
8. Wirtz K, Tauscher M, Zwerenz M, Munte A. Data warehousing for Bavarian out-patient public health. http://subs.emis.de/LNI/Proceedings/Proceedings91/GI-Proceedings-91-23.pdf. Accessed December 17, 2012.
9. Project Mondriaan . http://www.projectmondriaan.nl. Accessed December 17, 2012.
10. de Abajo FJ, Montero D, Madurga M, Garcia Rodriguez LA. Acute and clinically relevant drug-induced liver injury: a population based case-control study. Br J Clin Pharmacol Jul 2004; 58(1): 71-80.
11. Chalasani N, Fontana RJ, Bonkovsky HL, et al. Causes, clinical features, and outcomes from a prospective study of drug-induced liver injury in the United States. Gastroenterology. Dec 2008; 135(6): 1924-1934, 1934 e1921-1924.
12. Ibanez L, Perez E, Vidal X, Laporte JR. Prospective surveillance of acute serious liver disease unrelated to infectious, obstructive, or metabolic diseases: epidemiological and clinical features, and exposure to drugs. J Hepatol Nov 2002; 37(5): 592-600.
13. Antimicrobial ECDC. Resistance and healthcare-associated infections programme. Antibiotic resistance in Europe: the challenges ahead. Euro Surveill 2009; 14(45): 1-2.
14. The Pharmacoepidemiological Research on Outcomes of Therapeutics by a European Consortium (PROTECT). Objectives of PROTECT. http://www.imi-protect.eu/objectives.html . Accessed December 17, 2012.
15. Herrett E, Thomas SL, Schoonen WM, Smeeth L, Hall AJ. Validation and validity of diagnoses in the General Practice Research Database: a systematic review. Br J Clin Pharmacol Jan 2010; 69(1): 4-14.
16. Cai B, Xu W, Bortnichak E, Watson DJ. An algorithm to identify medical practices common to both the General Practice Research Database and The Health Improvement Network database. Pharmacoepidemiol Drug Saf Jul 2012; 21(7): 770-774.
17. Kassenärztliche Vereinigung Bayerns (KVB). The Bavarian Association of Statutory Health Insurance Physicians. http://www.kvb.de/fileadmin/kvb/dokumente/UeberUns/KVB-About-us.pdf. Accessed December 17, 2012.
18. Danish Health and Medicines Authority (DKMA). http://www.sst.dk/English. Accessed December 17, 2012.
19. European Commission . Database: population on 1 January by age and sex. http://epp.eurostat.ec.europa.eu/portal/page/portal/population/data/database. Accessed December 17, 2012.
20. Nederlands Instituut voor onderzoek naar de gezondheidszorg (NIVEL). Representatiteit van LINH (representativeness of LINH). http://www.nivel.nl/representativiteit-van-linh. Accessed December 17, 2012.
21. Blak BT, Thompson M, Dattani H, Bourke A. Generalisability of the Health Improvement Network (THIN) database: demographics, chronic disease prevalence and mortality rates. Inform Prim Care 2011; 19(4): 251-255.
22. Lawson DH, Sherman V, Hollowell J. The General Practice Research Database. Scientific and Ethical Advisory Group QJMJun 1998; 91(6): 445-452.
23. Verlee L, Verheij TJ, Hopstaken RM, Prins JM, Salome PL, Bindels PJ. [Summary of NHG practice guideline 'Acute cough']. Ned Tijdschr Geneeskd 2012; 156(0): A4188.
24. Onnouw EGJ. Kwaliteitstoetsing van huisartsenposten: Worden de NHG standaarden ten aanzien van antibiotica gebruik nageleefd? Nijmegen: Medicine, UMC St Radboud, 2007.
25. Lazaro-Bengoa E, Iglesias FJ, Lopez-Navas A, Fernandez-Cortizo MJ. Use of antibiotics in Spain and regulatory framework for clinical development in the European Union. Enferm Infecc Microbiol Clin Nov 2010; 28(Suppl 4): 10-16.